Ross G. Clark
Nessuna posizione attualmente
Storia della carriera di Ross G. Clark
Precedenti posizioni note di Ross G. Clark
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Direttore/Membro del Consiglio | 01/12/2001 | 21/06/2008 |
| Direttore Tecnico/Scientifico/R&S | 01/12/2001 | 21/06/2008 | |
| Auckland University | Corporate Officer/Principal | 01/09/1997 | 21/06/2008 |
| NeuronZ Ltd. | Direttore Tecnico/Scientifico/R&S | 01/10/1997 | 01/01/2000 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1990 | 01/01/1997 |
| ViaLactia Biosciences (NZ) Ltd. | Direttore/Membro del Consiglio | 01/07/1999 | - |
| Tercica Ltd. | Corporate Officer/Principal | 01/09/2000 | - |
Formazione di Ross G. Clark
| Massey University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Nuova-Zelanda | 6 |
| Stati Uniti | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
| Tercica Ltd. | |
| NeuronZ Ltd. | |
| ViaLactia Biosciences (NZ) Ltd. |
- Borsa valori
- Insiders
- Ross G. Clark
- Esperienza
